603882 金域医学
已收盘 05-16 15:00:00
资讯
新帖
简况
《新财富》最佳上市公司评选,金域医学斩获两项大奖
金域医学 · 05-14 10:33
《新财富》最佳上市公司评选,金域医学斩获两项大奖
应收账款存风险 金域医学增长乏力
经济参考网 · 05-14 08:43
应收账款存风险 金域医学增长乏力
金域医学05月14日主力净流出616.1万元 散户资金买入
市场透视 · 05-14 07:21
金域医学05月14日主力净流出616.1万元 散户资金买入
金域医学涨5.40%,国金证券二周前给出“买入”评级
证券之星 · 05-13 08:27
金域医学涨5.40%,国金证券二周前给出“买入”评级
A股医疗服务板块持续拉升,华大基因涨超10%,迪安诊断、贝瑞基因涨超7%,金域医学、美年健康跟涨。
美港电讯 · 05-13
A股医疗服务板块持续拉升,华大基因涨超10%,迪安诊断、贝瑞基因涨超7%,金域医学、美年健康跟涨。
太平洋:给予金域医学买入评级
证券之星 · 05-11
太平洋:给予金域医学买入评级
AD早筛新突破:P-tau217单指标诊断效能表现更佳!
IVD资讯 · 05-10
AD早筛新突破:P-tau217单指标诊断效能表现更佳!
金域医学05月08日主力净流入2062.9万元 散户资金抛售
市场透视 · 05-08
金域医学05月08日主力净流入2062.9万元 散户资金抛售
金域医学:医保控费政策+应收减值影响短期业绩 看好ICL持续复苏和AI赋能
中泰证券 · 05-07
金域医学:医保控费政策+应收减值影响短期业绩 看好ICL持续复苏和AI赋能
金域医学05月06日主力净流入1609.6万元 散户资金抛售
市场透视 · 05-06
金域医学05月06日主力净流入1609.6万元 散户资金抛售
吸引近千人在线参会,金域医学携手权威专家共探感染病理精准诊断
金域医学 · 04-30
吸引近千人在线参会,金域医学携手权威专家共探感染病理精准诊断
金域医学04月29日主力净流入3196万元 散户资金抛售
市场透视 · 04-29
金域医学04月29日主力净流入3196万元 散户资金抛售
金域医学涨5% 2024年年报业绩
智选洞察 · 04-29
金域医学涨5% 2024年年报业绩
金域医学新注册《金域云检KMC预约送检全流程管理系统V1.5》等3个项目的软件著作权
证券之星 · 04-28
金域医学新注册《金域云检KMC预约送检全流程管理系统V1.5》等3个项目的软件著作权
拆解医疗行业数据资源入表|应收账款占比超四成,借力数据要素布局精准医疗能否破题?
21财经网 · 04-28
拆解医疗行业数据资源入表|应收账款占比超四成,借力数据要素布局精准医疗能否破题?
金域医学:2024&1Q25业绩符合预期 深化数智化转型
中金公司 · 04-27
金域医学:2024&1Q25业绩符合预期 深化数智化转型
中国银河:给予金域医学买入评级
证券之星 · 04-27
中国银河:给予金域医学买入评级
金域医学净利暴跌 159.26%,股东高位套现90 亿元,坏账阴云难散|财报异动透视镜
新浪财经 · 04-27
金域医学净利暴跌 159.26%,股东高位套现90 亿元,坏账阴云难散|财报异动透视镜
金域医学一季度亏损同比扩大至2779万元
财中社 · 04-27
金域医学一季度亏损同比扩大至2779万元
金域医学2025年一季报简析:净利润减49.09%,公司应收账款体量较大
证券之星 · 04-26
金域医学2025年一季报简析:净利润减49.09%,公司应收账款体量较大
加载更多
公司概况
公司名称:
广州金域医学检验集团股份有限公司
所属行业:
卫生
上市日期:
2017-09-08
主营业务:
广州金域医学检验集团股份有限公司一家以第三方医学检验及病理诊断业务为核心的高科技服务企业,致力于为全国各级医疗机构提供符合国际标准的医学检验诊断信息整合服务。公司所提供的主要服务如下:医学检验及病理诊断类、非医学检验检测类、试剂销售、试剂生产、检验信息服务、医疗冷链物流。2023年,公司“健康哨兵五维质量管理模式”被收录在《21世纪中国质量管理最佳实践集萃》;金域医学30年质量经营哲学——《质量就是生命》成功出版,并入选“21世纪中国质量管理最佳实践系列丛书”,成为国内医学检测行业唯一代表。
发行价格:
6.93
{"stockData":{"symbol":"603882","market":"SH","secType":"STK","nameCN":"金域医学","latestPrice":30.5,"timestamp":1747378800000,"preClose":30.93,"halted":0,"volume":4440186,"delay":0,"changeRate":-0.0139,"floatShares":459999999,"shares":463000000,"eps":-0.8428,"marketStatus":"已收盘","change":-0.43,"latestTime":"05-16 15:00:00","open":30.8,"high":31.24,"low":30.44,"amount":137000000,"amplitude":0.0259,"askPrice":30.5,"askSize":732,"bidPrice":30.49,"bidSize":170,"shortable":0,"etf":0,"ttmEps":-0.8428,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747618200000},"marketStatusCode":5,"adr":0,"adjPreClose":30.93,"symbolType":"stock","openAndCloseTimeList":[[1747359000000,1747366200000],[1747371600000,1747378800000]],"highLimit":34.02,"lowLimit":27.84,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":463258275,"isCdr":false,"pbRate":2.05,"roa":"--","roe":"--","epsLYR":-0.82,"committee":-0.467391,"marketValue":14129000000,"turnoverRate":0.0096,"status":1,"floatMarketCap":14034000000},"requestUrl":"/m/hq/s/603882","defaultTab":"news","newsList":[{"id":"2535070327","title":"《新财富》最佳上市公司评选,金域医学斩获两项大奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2535070327","media":"金域医学","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535070327?lang=zh_cn&edition=full","pubTime":"2025-05-14 18:33","pubTimestamp":1747218797,"startTime":"0","endTime":"0","summary":"5月7日,“东吴证券2025经济与投资峰会暨新财富杂志最佳上市公司评选、最佳港股公司评选颁奖典礼”在上海盛大开启。据悉,《新财富》杂志最佳上市公司评选是中国资本市场最受瞩目的年度盛事之一,素有中国资本市场“奥斯卡”之称。同时,《新财富》杂志综合ESG相关指标及尽职调查情况,遴选出50家在ESG实践方面具有领先示范作用的公司,以此助推上市公司引领绿色发展、履行社会责任、提升公司治理水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515002802a47e65da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515002802a47e65da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603882","BK0284","BK0236","SG9999001069.SGD","BK0042"],"gpt_icon":0},{"id":"2535496420","title":"应收账款存风险 金域医学增长乏力","url":"https://stock-news.laohu8.com/highlight/detail?id=2535496420","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535496420?lang=zh_cn&edition=full","pubTime":"2025-05-14 16:43","pubTimestamp":1747212180,"startTime":"0","endTime":"0","summary":"2020—2024年金域医学业绩走势对于业绩的下滑,除了市场需求增长放缓等行业因素的影响,应收账款是影响金域医学增长的风险因素。根据年报,部分应收账款回款周期延长,导致产生信用减值损失金额较大,2024年信用减值损失6.19亿元,应收账款预期信用损失准备金额存在重大风险,应收账款的坏账准备被认定为关键审计事项。年报显示,从行业来看,由于公司业务的应收回款普遍不及预期,应收账款金额较大,回款天数有进一步增长的趋势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514172140975946fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514172140975946fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603882","SG9999001069.SGD","BK0284","BK0042","BK0236"],"gpt_icon":0},{"id":"2535049661","title":"金域医学05月14日主力净流出616.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2535049661","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535049661?lang=zh_cn&edition=full","pubTime":"2025-05-14 15:21","pubTimestamp":1747207295,"startTime":"0","endTime":"0","summary":"05月14日, 金域医学股价跌0.43%,报收32.26元,成交金额2.3亿元,换手率1.52%,振幅2.56%,量比0.85。金域医学今日主力资金净流出616.1万元,上一交易日主力净流入2850.4万元。该股近5个交易日上涨5.08%,主力资金累计净流入1977.8万元;近20日主力资金累计净流出4509.5万元,其中净流出天数为12日。|05月14日主力加仓幅度排名||#|股票简称|主力净额占比|#|中集环科|14.76%|#|襄阳轴承|6.23%|#|跨境通|5.97%|#|...|...|#2921|金域医学|-0.04%|金域医学所在的医疗服务行业,今日主力净流出6533万元,行业排名54/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514173127a47df460&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514173127a47df460&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0284","BK0042","BK0236","SG9999001069.SGD","603882"],"gpt_icon":0},{"id":"2535716999","title":"金域医学涨5.40%,国金证券二周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2535716999","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535716999?lang=zh_cn&edition=full","pubTime":"2025-05-13 16:27","pubTimestamp":1747124867,"startTime":"0","endTime":"0","summary":"今日金域医学涨5.40%,收盘报32.4元。2025年4月28日,国金证券研究员袁维发布了对金域医学的研报《数智化转型加速,成本控制持续推进》,该研报对金域医学给出“买入”评级。研报中预计25-27年归母净利润为1.45/4.93/5.53亿元,分别同比增长NA、240%、12%,EPS分别为0.31、1.06、1.20元,现价对应PE为88、26、23倍,维持“买入”评级。此外,中国银河研究员程培,孟熙,太平洋研究员谭紫媚,李啸岩近期也对该股发布了研报,同样给出“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051300025066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882"],"gpt_icon":0},{"id":"2535793764","title":"A股医疗服务板块持续拉升,华大基因涨超10%,迪安诊断、贝瑞基因涨超7%,金域医学、美年健康跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535793764","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535793764?lang=zh_cn&edition=full","pubTime":"2025-05-13 14:06","pubTimestamp":1747116413,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0046","BK0102","BK0221","300676","BK0086","LU2097828631.EUR","LU2097828557.USD","LU2097828474.EUR","BK0196","BK0197","BK0284","159982","BK0186","LU2097828714.EUR","BK0028","399300","BK0139","300244","SG9999001069.SGD","603882","BK0114","LU2097828805.USD","BK0070","BK0042","BK0146","000710","BK0081","BK0077","002044","BK0236"],"gpt_icon":0},{"id":"2534400671","title":"太平洋:给予金域医学买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2534400671","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534400671?lang=zh_cn&edition=full","pubTime":"2025-05-11 16:55","pubTimestamp":1746953715,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司谭紫媚,李啸岩近期对金域医学进行研究并发布了研究报告《金域医学点评报告:业绩短期承压,数智化转型加速》,给予金域医学买入评级。维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有10家机构给出评级,买入评级10家;过去90天内机构目标均价为39.81。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051100001503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","601099"],"gpt_icon":0},{"id":"2534449629","title":"AD早筛新突破:P-tau217单指标诊断效能表现更佳!","url":"https://stock-news.laohu8.com/highlight/detail?id=2534449629","media":"IVD资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534449629?lang=zh_cn&edition=full","pubTime":"2025-05-10 14:24","pubTimestamp":1746858268,"startTime":"0","endTime":"0","summary":"成果发表于《Front Aging Neurosci》IF=4.8单一指标血浆P-tau217诊断性能更佳阿尔茨海默病是最常见的神经系统退行性疾病,目前中国患者数已超1000万,是全球患者群体数目最庞大的国家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250510182625a47923f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250510182625a47923f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0284","BK0236","603882","BK0042","SG9999001069.SGD"],"gpt_icon":0},{"id":"2533972521","title":"金域医学05月08日主力净流入2062.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2533972521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533972521?lang=zh_cn&edition=full","pubTime":"2025-05-08 15:20","pubTimestamp":1746688832,"startTime":"0","endTime":"0","summary":"05月08日, 金域医学股价涨0.49%,报收30.85元,成交金额2.2亿元,换手率1.55%,振幅3.39%,量比0.67。金域医学今日主力资金净流入2062.9万元,上一交易日主力净流出1209.1万元。该股近5个交易日上涨11.21%,主力资金累计净流入4092.5万元;近20日主力资金累计净流出5131.0万元,其中净流出天数为12日。|05月08日主力加仓幅度排名||#|股票简称|主力净额占比|#|*ST双成|8.61%|#|跨境通|7.99%|#|中百集团|7.29%|#|...|...|#856|金域医学|0.15%|金域医学所在的医疗服务行业,今日主力净流出4968万元,行业排名52/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508171514a47673e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508171514a47673e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999001069.SGD","BK0042","BK0236","603882","BK0284"],"gpt_icon":0},{"id":"2533187930","title":"金域医学:医保控费政策+应收减值影响短期业绩 看好ICL持续复苏和AI赋能","url":"https://stock-news.laohu8.com/highlight/detail?id=2533187930","media":"中泰证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533187930?lang=zh_cn&edition=full","pubTime":"2025-05-08 00:00","pubTimestamp":1746633600,"startTime":"0","endTime":"0","summary":"事件:公司发布2024 年年度报告及2025 年一季报,2024 年公司实现营业收入71.90亿元,同比下降15.81%,实现归母净利润-3.81 亿元,同比下降159.26%,实现扣非净利润-2.38 亿元,同比下降165.28%。2024 年,医保控费政策深化,DRG/DIP 支付改革全面落地,市场竞争相对激烈,检验外包价格持续调整,ICL行业整体面临一定压力。我们预计医改政策全面落地后ICL 行业有望加速出清,市场竞争有望趋缓,公司常规检验业务有望逐渐迎来恢复。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508202631a6d7b330&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508202631a6d7b330&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999001069.SGD","BK0042","BK0236","BK0284","603882"],"gpt_icon":0},{"id":"2533508075","title":"金域医学05月06日主力净流入1609.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2533508075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533508075?lang=zh_cn&edition=full","pubTime":"2025-05-06 15:20","pubTimestamp":1746516022,"startTime":"0","endTime":"0","summary":"05月06日, 金域医学股价涨5.70%,报收30.77元,成交金额3.9亿元,换手率2.79%,振幅6.42%,量比1.31。金域医学今日主力资金净流入1609.6万元,上一交易日主力净流出1567.0万元。该股近5个交易日上涨8.65%,主力资金累计净流出1522.4万元;近20日主力资金累计净流出1.0亿元,其中净流出天数为13日。该行业中净流入前三个股分别为金凯生科、皓元医药、泓博医药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506164818a473c0f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506164818a473c0f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603882","BK0042","BK0236","BK0284","SG9999001069.SGD"],"gpt_icon":0},{"id":"2531803997","title":"吸引近千人在线参会,金域医学携手权威专家共探感染病理精准诊断","url":"https://stock-news.laohu8.com/highlight/detail?id=2531803997","media":"金域医学","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531803997?lang=zh_cn&edition=full","pubTime":"2025-04-30 19:19","pubTimestamp":1746011962,"startTime":"0","endTime":"0","summary":"2024年,金域医学全新推出的MetaPath,刚好弥补了感染性病变病理诊断上的不足。在妇科肿瘤诊断方面,金域医学曾收到一例较为少见的宫颈癌病例样本。在消化病理诊断方面,MetaPath更是展示出应对混合感染精准诊断的独特魅力。本次会议,凝聚了临床对感染病理诊断的共识,启发了上千名同行对感染病理分子诊断的思考。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430195205a46daa5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430195205a46daa5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999001069.SGD","603882","BK0236","BK0284","BK0042"],"gpt_icon":0},{"id":"2531027173","title":"金域医学04月29日主力净流入3196万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2531027173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531027173?lang=zh_cn&edition=full","pubTime":"2025-04-29 15:20","pubTimestamp":1745911214,"startTime":"0","endTime":"0","summary":"04月29日, 金域医学股价涨4.36%,报收28.95元,成交金额3.4亿元,换手率2.55%,振幅6.67%,量比1.38。金域医学今日主力资金净流入3196万元,上一交易日主力净流出1368万元。该股近5个交易日下跌0.10%,主力资金累计净流出4269万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出1.1亿元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429163642a46bc42e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429163642a46bc42e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999001069.SGD","BK0042","BK0236","603882","BK0284"],"gpt_icon":0},{"id":"2531210435","title":"金域医学涨5% 2024年年报业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2531210435","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531210435?lang=zh_cn&edition=full","pubTime":"2025-04-29 10:20","pubTimestamp":1745893231,"startTime":"0","endTime":"0","summary":"04月29日,金域医学股价大幅上涨,截至10点20分,金域医学上涨5.01%,报29.13元/股,成交1.98亿元,换手率1.50%。消息解读金域医学近日公布了2024年年报及2025年一季报,显示公司在多个方面取得了显著进展。最新财报显示,今年一季报,金域医学实现营业收入14.67亿元,同比减少20.35%,净利润为-2,778.53万元,同比减少49.09%,基本每股收益为-0.06元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910224897495d30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910224897495d30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0284","BK0236","SG9999001069.SGD","603882","BK0042"],"gpt_icon":0},{"id":"2531915251","title":"金域医学新注册《金域云检KMC预约送检全流程管理系统V1.5》等3个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2531915251","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531915251?lang=zh_cn&edition=full","pubTime":"2025-04-29 02:46","pubTimestamp":1745865995,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金域医学(603882)新注册了3个项目的软件著作权,包括《金域云检KMC预约送检全流程管理系统V1.5》、《金域标本库管理系统V1.0》、《金域医学客户关系运营分析看板系统V1.2.12》等。今年以来金域医学新注册软件著作权53个,较去年同期增加了488.89%。结合公司2024年年报财务数据,2024年公司在研发方面投入了4亿元,同比减14.27%。数据来源:企查查以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900001422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","BK0042","BK0236","SG9999001069.SGD","603882"],"gpt_icon":0},{"id":"2530764974","title":"拆解医疗行业数据资源入表|应收账款占比超四成,借力数据要素布局精准医疗能否破题?","url":"https://stock-news.laohu8.com/highlight/detail?id=2530764974","media":"21财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530764974?lang=zh_cn&edition=full","pubTime":"2025-04-28 18:30","pubTimestamp":1745836242,"startTime":"0","endTime":"0","summary":"报告期内,金域医学营业收入同比减少15.81%。美年健康、何氏眼科和华大基因三家医疗企业也于近日在2024年报中披露了数据资源入表金额,四家企业合计披露金额达2688.7亿元。其中,华大基因以962.17万元的入表规模居行业首位,确认为无形资产的数据资源均为外部购入的数据治理平台。相较而言,金域医学在数据要素领域动作最多、布局最深。据悉,此次入表的数据资产已通过匿名化技术处理后在数据交易所完成登记。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428183115974858a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428183115974858a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603882","BK0236","BK0284","159891","399418","SG9999001069.SGD","BK0042"],"gpt_icon":0},{"id":"2530750444","title":"金域医学:2024&1Q25业绩符合预期 深化数智化转型","url":"https://stock-news.laohu8.com/highlight/detail?id=2530750444","media":"中金公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530750444?lang=zh_cn&edition=full","pubTime":"2025-04-28 00:00","pubTimestamp":1745769600,"startTime":"0","endTime":"0","summary":"2024 全年计提信用减值损失6.19 亿元,固定资产报废损失1.44 亿元,投资企业公允价值损失9,904 万元,带动净利润端同比转亏;1Q25 公司计提信用减值损失1.06 亿元,造成1Q25 出现净亏损,我们预计2025 全年信用减值损失仍对表观净利润带来一定程度影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428152617a6cb4649&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428152617a6cb4649&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0284","603882","BK0042","BK0236","SG9999001069.SGD"],"gpt_icon":0},{"id":"2530045840","title":"中国银河:给予金域医学买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2530045840","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530045840?lang=zh_cn&edition=full","pubTime":"2025-04-27 21:08","pubTimestamp":1745759286,"startTime":"0","endTime":"0","summary":"中国银河证券股份有限公司程培,孟熙近期对金域医学进行研究并发布了研究报告《2024年年报及2025年一季报业绩点评:政策影响持续,等待经营拐点》,给予金域医学买入评级。最新盈利预测明细如下:该股最近90天内共有9家机构给出评级,买入评级9家;过去90天内机构目标均价为38.65。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042700009973.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601881","603882"],"gpt_icon":0},{"id":"2530452436","title":"金域医学净利暴跌 159.26%,股东高位套现90 亿元,坏账阴云难散|财报异动透视镜","url":"https://stock-news.laohu8.com/highlight/detail?id=2530452436","media":"新浪财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530452436?lang=zh_cn&edition=full","pubTime":"2025-04-27 18:01","pubTimestamp":1745748060,"startTime":"0","endTime":"0","summary":"净利润暴跌159.26%2024年,金域医学实现营业收入71.90亿元,较上年同期的85.40亿元下降15.81%。截至2024年9月末,金域医学的应收账款还高达51.16亿元,此番计提后,仍有超过40亿元的历史遗留问题待解。具体来看,2024年前三个季度,金域医学分别计提信用减值损失1.40亿元、1.56亿元、1.25亿元,第四季度的信用减值损失为2.29亿元至2.99亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042718071194e49c5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042718071194e49c5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603882"],"gpt_icon":0},{"id":"2530107915","title":"金域医学一季度亏损同比扩大至2779万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530107915","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530107915?lang=zh_cn&edition=full","pubTime":"2025-04-27 11:07","pubTimestamp":1745723238,"startTime":"0","endTime":"0","summary":"4月25日,金域医学公布2025年一季报,公司营业收入为14.7亿元,同比下降20.4%;归母净利润自去年同期亏损1864万元变为亏损2779万元,亏损额进一步扩大;扣非归母净利润自去年同期亏损2929万元变为亏损3870万元,亏损额进一步扩大;经营现金流净额为5450万元,同比增长139.4%;EPS为-0.06元。截至一季度末,公司总资产98.55亿元,较上年度末下降5.2%;归母净资产为68.88亿元,较上年度末下降6.0%。文章来源:财中社金域医学一季度亏损同比扩大至2779万元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427113224a468b4b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427113224a468b4b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0236","603882","BK0284","SG9999001069.SGD","BK0042"],"gpt_icon":0},{"id":"2530510177","title":"金域医学2025年一季报简析:净利润减49.09%,公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2530510177","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530510177?lang=zh_cn&edition=full","pubTime":"2025-04-27 06:17","pubTimestamp":1745705865,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期金域医学发布2025年一季报。截至本报告期末,公司营业总收入14.67亿元,同比下降20.35%,归母净利润-2778.53万元,同比下降49.09%。本报告期金域医学公司应收账款体量较大,当期应收账款占最新年报营业总收入比达60.1%。持有金域医学最多的基金为长城消费增值混合A,目前规模为5.49亿元,最新净值0.9748,较上一交易日下跌0.57%,近一年下跌7.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427062712a4687933&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427062712a4687933&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603882"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1747381767469,"stockEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":0.0669},{"period":"3month","weight":-0.1289},{"period":"6month","weight":-0.0439},{"period":"1year","weight":-0.0943},{"period":"ytd","weight":0.1486}],"compareEarnings":[{"period":"1week","weight":0.0086},{"period":"1month","weight":0.0346},{"period":"3month","weight":0.0102},{"period":"6month","weight":0.015},{"period":"1year","weight":0.0836},{"period":"ytd","weight":0.0087}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州金域医学检验集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"43987人(较上一季度增加20.88%)","perCapita":"10460股","listingDate":"2017-09-08","address":"广东省广州市海珠区国际生物岛螺旋三路10号","registeredCapital":"46325万元","survey":" 广州金域医学检验集团股份有限公司一家以第三方医学检验及病理诊断业务为核心的高科技服务企业,致力于为全国各级医疗机构提供符合国际标准的医学检验诊断信息整合服务。公司所提供的主要服务如下:医学检验及病理诊断类、非医学检验检测类、试剂销售、试剂生产、检验信息服务、医疗冷链物流。2023年,公司“健康哨兵五维质量管理模式”被收录在《21世纪中国质量管理最佳实践集萃》;金域医学30年质量经营哲学——《质量就是生命》成功出版,并入选“21世纪中国质量管理最佳实践系列丛书”,成为国内医学检测行业唯一代表。","listedPrice":6.93},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.5","shortVersion":"4.33.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金域医学(603882)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金域医学(603882)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金域医学,603882,金域医学股票,金域医学股票老虎,金域医学股票老虎国际,金域医学行情,金域医学股票行情,金域医学股价,金域医学股市,金域医学股票价格,金域医学股票交易,金域医学股票购买,金域医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金域医学(603882)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金域医学(603882)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}